These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 11454718

  • 21. Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability--evidence of E2F-1 transcriptional control over hCdt1.
    Karakaidos P, Taraviras S, Vassiliou LV, Zacharatos P, Kastrinakis NG, Kougiou D, Kouloukoussa M, Nishitani H, Papavassiliou AG, Lygerou Z, Gorgoulis VG.
    Am J Pathol; 2004 Oct; 165(4):1351-65. PubMed ID: 15466399
    [Abstract] [Full Text] [Related]

  • 22. Triggering of p73-dependent apoptosis in osteosarcoma is under the control of E2Fs-pRb2/p130 complexes.
    La Sala D, Macaluso M, Trimarchi C, Giordano A, Cinti C.
    Oncogene; 2003 Jun 05; 22(23):3518-29. PubMed ID: 12789260
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. p14ARF links the tumour suppressors RB and p53.
    Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL, Vousden KH.
    Nature; 1998 Sep 10; 395(6698):124-5. PubMed ID: 9744267
    [No Abstract] [Full Text] [Related]

  • 27. Mutational analysis of p73 and p53 in human cancer cell lines.
    Yoshikawa H, Nagashima M, Khan MA, McMenamin MG, Hagiwara K, Harris CC.
    Oncogene; 1999 Jun 03; 18(22):3415-21. PubMed ID: 10362363
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The role of the transcription factor DP in apoptosis.
    Hitchens MR, Robbins PD.
    Apoptosis; 2003 Oct 03; 8(5):461-8. PubMed ID: 12975577
    [Abstract] [Full Text] [Related]

  • 30. E2F-1 induced apoptosis.
    Phillips AC, Vousden KH.
    Apoptosis; 2001 Jun 03; 6(3):173-82. PubMed ID: 11388666
    [Abstract] [Full Text] [Related]

  • 31. Different intracellular compartmentalization of TA and DeltaNp73 in non-small cell lung cancer.
    Di Vinci A, Sessa F, Casciano I, Banelli B, Franzi F, Brigati C, Allemanni G, Russo P, Dominioni L, Romani M.
    Int J Oncol; 2009 Feb 03; 34(2):449-56. PubMed ID: 19148480
    [Abstract] [Full Text] [Related]

  • 32. p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma.
    Mori S, Ito G, Usami N, Yoshioka H, Ueda Y, Kodama Y, Takahashi M, Fong KM, Shimokata K, Sekido Y.
    Cancer; 2004 Apr 15; 100(8):1673-82. PubMed ID: 15073856
    [Abstract] [Full Text] [Related]

  • 33. Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis.
    Vorburger SA, Pataer A, Yoshida K, Barber GN, Xia W, Chiao P, Ellis LM, Hung MC, Swisher SG, Hunt KK.
    Oncogene; 2002 Sep 12; 21(41):6278-88. PubMed ID: 12214268
    [Abstract] [Full Text] [Related]

  • 34. Genetic alterations of the p14ARF -hdm2-p53 regulatory pathway in breast carcinoma.
    Ho GH, Calvano JE, Bisogna M, Abouezzi Z, Borgen PI, Cordón-Cardó C, van Zee KJ.
    Breast Cancer Res Treat; 2001 Feb 12; 65(3):225-32. PubMed ID: 11336244
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
    Raveh T, Droguett G, Horwitz MS, DePinho RA, Kimchi A.
    Nat Cell Biol; 2001 Jan 12; 3(1):1-7. PubMed ID: 11146619
    [Abstract] [Full Text] [Related]

  • 37. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene.
    Pinyol M, Hernández L, Martínez A, Cobo F, Hernández S, Beà S, López-Guillermo A, Nayach I, Palacín A, Nadal A, Fernández PL, Montserrat E, Cardesa A, Campo E.
    Am J Pathol; 2000 Jun 12; 156(6):1987-96. PubMed ID: 10854221
    [Abstract] [Full Text] [Related]

  • 38. DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.
    Domínguez G, García JM, Peña C, Silva J, García V, Martínez L, Maximiano C, Gómez ME, Rivera JA, García-Andrade C, Bonilla F.
    J Clin Oncol; 2006 Feb 10; 24(5):805-15. PubMed ID: 16380414
    [Abstract] [Full Text] [Related]

  • 39. The expression of p73 is increased in lung cancer, independent of p53 gene alteration.
    Tokuchi Y, Hashimoto T, Kobayashi Y, Hayashi M, Nishida K, Hayashi S, Imai K, Nakachi K, Ishikawa Y, Nakagawa K, Kawakami Y, Tsuchiya E.
    Br J Cancer; 1999 Jul 10; 80(10):1623-9. PubMed ID: 10408409
    [Abstract] [Full Text] [Related]

  • 40. DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.
    Marabese M, Vikhanskaya F, Rainelli C, Sakai T, Broggini M.
    Nucleic Acids Res; 2003 Nov 15; 31(22):6624-32. PubMed ID: 14602923
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.